7Baggers
 Genprex (GNPX) Files to Sell 25 Million Common Shares  GuruFocus Fri, 12 Sep 2025 07:00:00 GMT
 Genprex Is Betting On Gene Therapy, But Risks Remain High  Finimize Thu, 11 Sep 2025 14:55:14 GMT
 genprex secures patent allowances for gene therapy  MSN Mon, 08 Sep 2025 04:03:51 GMT
 published on: 2025-09-03 03:25:28  Newser Wed, 03 Sep 2025 08:25:28 GMT
 genprex secures patent allowances for gene therapy  MSN Wed, 03 Sep 2025 04:41:24 GMT
 genprex secures patent allowances for gene therapy  MSN Tue, 02 Sep 2025 19:54:34 GMT

Genprex, Inc
(NASDAQ:GNPX) 

GNPX stock logo

Genprex, Inc. operates as a clinical-stage gene therapy company that develops treatments for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new treatment options for patient populations with cancer and diabetes. Its lead pro...

Founded: 2009
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends